VAERS reports by lot

Pfizer COVID-19 lot EWO158: VAERS reports

57 VAERS reports list lot EWO158 as a Pfizer COVID-19 vaccine, received between 2021-04-08 and 2023-06-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
57
Reports
14%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5625%
Neurological5223%
Musculoskeletal2812%
Cardiac / Cardiovascular198%
Dermatological (non-injection-site)177%
Gastrointestinal167%
Injection-site / Local reaction115%
Respiratory94%
Psychiatric / Neuropsychiatric84%
Allergic / Anaphylactic63%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated21%
Reproductive / Menstrual21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Indiana11
New York6
Kentucky5
Ohio3
California3
Maryland2
Illinois2
Florida2
Massachusetts2
South Carolina2
Wisconsin2
Oregon2

Reports by month received

2021-0422
2021-057
2021-062
2021-076
2021-081
2021-095
2021-106
2021-111
2022-022
2022-031
2022-071
2022-111
2023-041
2023-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.